Qlucore Partners with Commugene in South Korean
News Sep 19, 2014
As the world’s 12th largest economy, South Korea is one of the fastest growing and most exciting markets in the world. The recent EU-South Korea Free Trade Agreement (FTA) has resulted in the vast majority of tariffs being removed, and initiatives by the Korean Government such as Bio-Vision 2016 to step up competitiveness and improve infrastructure, has created opportunities for business.
The biotech industry is one of the fastest growing industries in Korea with an annual growth rate of 10%. South Korean publicly listed bioscience companies in 2013 registered combined revenue of $8.3 billion. Clinical trials are becoming more commonplace locally, but there is a strong demand for international partnerships to conform to global standards.
Keeping abreast with these developments, and eager to capitalize on opportunities by a global approach, Qlucore, a world leader in the development of bioinformatics software, has appointed a new agent in South Korea, Commugene.
Through the partnership with Commugene, researchers in the biotechnology industry will have easier access to Qlucore's highly intuitive software, Qlucore Omics Explorer. This data analysis tool, both extremely powerful and yet easy to use, will be invaluable for unveiling important new discoveries.
"We are delighted to be entering into this agreement with Commugene, as we are confident that this cooperation will help researchers in South Korea to learn more about our software, and to achieve extraordinary results with their data analysis." commented Carl-Johan Ivarsson, President, Qlucore.
Qlucore Omics Explorer is unique in that it allows the actual researchers - the people with the most biological insight - to study their own data and to look for patterns and structures. As a result, researchers do not need to be statistics or computer experts in order to use Qlucore Omics Explorer effectively.
"We have no doubt that Qlucore Omics Explorer will be very attractive to the scientific community in South Korea," commented Jeong-hun Kim, Director of Marketing &Sales of Commugene on the new partnership.
Kim continued, “The biotech and pharmaceutical sectors in South Korea are growing very quickly, which means that there is a strong demand for truly innovative solutions in these areas. We therefore expect to promote Qlucore’s software with great success.”
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE